MedTrace Logo

Esophageal String Test in Eosinophilic Esophagitis

NCT02008903 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 440

Last updated 2026-05-15

No results posted yet for this study

Summary

The overall goal of this study is to develop a novel minimally invasive device, the Esophageal String Test (EST) to monitor esophageal inflammation during treatment of the rare disease Eosinophilic Esophagitis (EoE) in a safe and efficacious manner.

This study is broken down into 2 specific aims:

Specific Aim 1: Identify the EoE Biomarker Panel (EBP) that will improve the sensitivity and specificity of the EST for documenting esophageal inflammation in a 1-hour time point.

Specific Aim 2: Validate the ability of the EST EBP to monitor therapeutic efficacy in a 1-hour sampling time.

Funding Source - FDA OOPD

Conditions

  • Eosinophilic Esophagitis

Sponsors & Collaborators

  • University of Colorado, Denver

    lead OTHER

  • University of Illinois at Chicago

    collaborator OTHER

  • Northwestern University

    collaborator OTHER

  • OSF Healthcare System

    collaborator OTHER

Principal Investigators

  • Glenn T Furuta, MD · Children's Hospital Colorado

Eligibility

Min Age
7 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2027-01-31
Completion
2027-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02008903 on ClinicalTrials.gov